Prevalence and Correlates of Physical Comorbidities in Alcohol Use Disorder (AUD)
A Pilot Study in Treatment-Seeking Population
Datos Bibliográficos
| ID | 15440912 |
|---|---|
| Autores | P V AshaRani (0000-0001-8215-5214, Institute of Mental Health, autor de correspondencia), Mohamed Zakir Karuvetil (Institute of Mental Health), Yeow Wee Brian Tan (0000-0003-0808-1848, Institute of Mental Health), Tan Yeow Wee Brian, Pratika Satghare (0000-0002-9258-5418, Institute of Mental Health), Kumarasan Roystonn (0000-0001-9100-0353, Institute of Mental Health), Peizhi Wang (0000-0002-7054-1879, Institute of Mental Health), Wang Peizhi, Laxman Cetty (0000-0001-7669-7607, Institute of Mental Health), Noor Azizah Bte Zainuldin (Institute of Mental Health), Noor Azizah Zainuldin, Mythily Subramaniam (0000-0003-4530-1096, National University of Singapore) |
| Año | 2022 |
| Volumen | 21 |
| Número | 4 |
| Páginas | 2508-2525 |
| Fecha de publicación | 2022-01-23 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Mental Health and Addiction (JOURNAL) |
| Identificadores de la revista | ISSN: 1557-1874 • E-ISSN: 1557-1882 |
| Editorial | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s11469-021-00734-5 |
| PMID | 35095353 |
| OpenAlex | W4207056349 |
| Idioma | EN |
| Citas recibidas | 3 |
| Referencias citadas | 62 |
This study aimed to understand the prevalence of physical comorbidities, undiagnosed and inadequately controlled chronic physical conditions and correlates of high cholesterol, hypertension and liver enzyme abnormalities in those with alcohol use disorder (AUD). Participants ( n = 101) with AUD were recruited from a tertiary care centre through convenient sampling. The prevalence of physical and psychiatric comorbidities in the sample was 83.17% and 51.49%, respectively. Around 53.47% had two or more chronic physical conditions (multimorbidity). Hypertension (44.55%), asthma (23.76%), high cholesterol (22.77%) and liver enzyme abnormalities (21.78%) were the top four physical comorbidities. The prevalence of undiagnosed and inadequately controlled chronic physical conditions was 61.4% and 32.7%, respectively. Gender, education and body mass index (BMI) were associated with hyperlipidaemia while age and education were associated with hypertension. Higher waist-hip ratio was associated with liver enzyme abnormalities. Routine clinical care must include regular screening and follow-up of the risk groups to monitor their physical and mental health
Alcohol · Alcohol use disorder · Body mass index · Comorbidity · Environmental health · Physical examination · Physical therapy · Population · Psychiatry · Alcohol Consumption and Health Effects · Diabetes, Cardiovascular Risks, and Lipoproteins · Medicine · Substance Abuse Treatment and Outcomes · Internal Medicine
Alcohol as a Risk Factor for Type 2 Diabetes
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the United States
Epidemic of Covid-19 in China and associated Psychological Problems
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (Pure)
Global Burden of Disease and the Impact of Mental and Addictive Disorders
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013
Alcohol use and burden for 195 countries and territories, 1990–2016
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States
National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use
The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
Smoking and Mental Illness
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments
Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore
| Obras citantes distintas | 3 |
|---|---|
| Citas por año | 3 |
| Intervalo de citas | 2025 - 2025 (1) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 3 |